Human Liver Explants for HIF-1 Alpha Analysis/Comparison (HIF HCC)

计划入组 180 人 · 首次发布于 2009 年 3 月 23 日

HAIC Combine With Lenvatinib and PD-1 Inhibitors for Advanced HCC With PVTT

计划入组 66 人 · 首次发布于 2021 年 12 月 21 日

Cardiovascular Outcomes SGLT-2 Inhibitors Versus GLP-1 Receptor Agonists

计划入组 10,000 人 · 首次发布于 2019 年 12 月 4 日

Dual HIF-1/HIF-2 inhibitor (Curve Therapeutics)

HIF-1 inhibitors (cancer)

HIF-1 alpha inhibitors (cancer)

NHI-1

United States

MEREO BIOPHARMA 2 LIMITED

United Kingdom

Xi'an No.1 Hospital

China

Novel Dual HIF-1/2 Inhibitors Achieve Complete Tumor Remission in Combination with Immunotherapy

Novel HIF-2α Inhibitor Casdatifan Shows Promise in Advanced Kidney Cancer Phase 1 Trial

Jeil Pharmaceutical's Dual SGLT-1/2 Inhibitor JP-2266 Shows Significant HbA1c Reduction in Phase 2 Diabetes Trial